Application 203012
- Type
- ANDA
- Sponsor
- ALEMBIC PHARMS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET;ORAL | 5MG | No | No |
| 002 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET;ORAL | 20MG | No | No |
| 003 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET;ORAL | 40MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 46708-131 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-131 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-131 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-132 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-132 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-132 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-133 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-133 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-133 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Limited | ANDA | Current |
| 62332-131 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-131 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-131 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-131 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-131 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-132 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-132 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-132 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-132 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-132 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-133 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-133 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-133 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-133 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-133 | Olmesartan Medoxomil | Olmesartan Medoxomil | Alembic Pharmaceuticals Inc. | ANDA | Current |